超声检查评估分化型甲状腺癌颈部转移淋巴结的研究进展

doi:10.16352/j.issn.1001-6325.2023.03.505

基础医学与临床 ›› 2023, Vol. 43 ›› Issue (3): 505-508.doi: 10.16352/j.issn.1001-6325.2023.03.505

超声检查评估分化型甲状腺癌颈部转移淋巴结的研究进展

田艳, 马姣姣, 席雪华, 张波^*

中日友好医院超声医学科,北京 100029

收稿日期:2021-11-23 修回日期:2022-04-15 出版日期:2023-03-05 发布日期:2023-02-27
通讯作者: * thyroidus@163.com
基金资助:
中央高校基本科研业务费专项资金资助(3332020076)

Progress in evaluation of cervical metastatic lymph nodes of differentiated thyroid cancer with ultrasonography

TIAN Yan, MA Jiaojiao, XI Xuehua, ZHANG Bo^*

Department of Ultrasound Medicine, China-Japan Friendship Hospital, Beijing 100029, China

Received:2021-11-23 Revised:2022-04-15 Online:2023-03-05 Published:2023-02-27
Contact: * thyroidus@163.com

摘要/Abstract

摘要： 颈部转移性淋巴结的准确评估对分化型甲状腺癌(DTC)患者的风险分期、治疗及预后均有重要意义,超声检查是颈部淋巴结评估的主要检查方法。近年来,随着弹性成像、超声造影、超声引导下细针穿刺细胞病理学及人工智能深度学习等新技术的出现及广泛应用,进一步提高了超声检查对DTC颈部转移性淋巴结的诊断能力。

关键词: 分化型甲状腺癌, 淋巴结转移, 超声检查

Abstract: Accurate evaluation of cervical metastatic lymph nodes is of great significance to the risk staging, treatment and prognosis of patients with differentiated thyroid cancer(DTC). Ultrasonography is the main examination method to evaluate cervical lymph nodes. In recent years, with the emergence and extensive application of new technologies such as elastic imaging, contrast-enhanced ultrasonography, fine needle aspiration cytology and artificial intelligence, the diagnostic effectiveness of cervical metastatic lymph nodes of DTC has been further improved.

Key words: differentiated thyroid carcinoma, lymph node metastasis, ultrasonography

中图分类号:

田艳, 马姣姣, 席雪华, 张波. 超声检查评估分化型甲状腺癌颈部转移淋巴结的研究进展[J]. 基础医学与临床, 2023, 43(3): 505-508.

TIAN Yan, MA Jiaojiao, XI Xuehua, ZHANG Bo. Progress in evaluation of cervical metastatic lymph nodes of differentiated thyroid cancer with ultrasonography[J]. Basic & Clinical Medicine, 2023, 43(3): 505-508.

参考文献

[1]Liu YC, Wang YZ, Zhao K, et al. Lymph node metastasis in young and middle-aged papillary thyroid carcinoma patients: a SEER-based cohort study[J]. BMC Cancer,2020,20:181.doi: 10.1186/s12885-020-6675-0.
[2]Maciel J, Donato S, Simões H, et al. Clinical outcomes of a conservative approach in cervical lymph node metastases of thyroid cancer[J]. Clin Endocrinol(Oxf),2021,94:460-465.
[3]Mandapathil M, Lennon P, Ganly I, et al. Significance and management of incidentally diagnosed metastatic papillary thyroid carcinoma in cervical lymph nodes in neck dissection specimens[J]. Head Neck,2019,41:3783-3787.
[4]Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid,2016,26:1-133.
[5]Abboud B, Smayra T, Jabbour H, et al. Correlations of neck ultrasound and pathology in cervical lymph node of papillary thyroid carcinoma[J]. Acta Chir Belg,2020,120:238-244.
[6]Wu X, Zhang L, Sun J, et al. Correlation between sonographic features and pathological findings of cervical lymph node metastasis of differentiated thyroid carcinoma[J]. Gland Surg, 2021,10:1736-1743.
[7]Attard A, Paladino NC, Lo Monte AI, et al. Skip metastases to lateral cervical lymph nodes in differentiated thyroid cancer: a systematic review[J]. BMC Surg,2019,18:112.doi: 10.1186/s12893-018-0435-y.
[8]Liu ZM, Zeng W, Liu CP, et al. Diagnostic accuracy of ultrasonographic features for lymph node metastasis in papillary thyroid microcarcinoma: a single-center retrospec-tive study[J]. World J Surg Oncol,2017,15:32.doi: 10.1186/s12957-017-1099-2.
[9]Giacomini CP, Jeffrey RB, Shin LK. Ultrasonographic evaluation of malignant and normal cervical lymph nodes[J]. Semin Ultrasound CT MR,2013,34:236-247.
[10]Chasen NN, Wang JR, Gan Q, et al. Imaging of cervical lymph nodes in thyroid cancer: ultrasound and computed tomography[J]. Neuroimaging Clin N Am,2021,31:313-326.
[11]Song JL, Yan T, Qiu WW, et al.Clinical analysis of risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: a retrospective study of 3686 patients[J].Cancer Manag Res,2020,12,2523-2530.
[12]Zhan J, Diao XH, Chen Y, et al. Homogeneity parameter in contrast-enhanced ultrasound imaging improves the classification of abnormal cervical lymph node after thyroidectomy in patients with papillary thyroid carcinoma[J]. Biomed Res Int,2019:9296010.doi: 10.1155/2019/9296010.
[13]Chen L, Chen LZ, Liu JH, et al. Value of qualitative and quantitative contrast-enhanced ultrasound analysis in preoperative diagnosis of cervical lymph node metastasis from papillary thyroid carcinoma[J].J Ultrasound Med,2020,39:73-81.
[14]Luo ZY, Hong YR, Yan CX, et al.Utility of quantitative contrast-enhanced ultrasound for the prediction of lymph node metastasis in patients with papillary thyroid carcinoma[J]. Clin Hemorheo Microcic,2022,80:37-48.
[15]Zhou W, Chen YD, Zhang L, et al.Percutaneous microwave ablation of metastatic lymph nodes from papillary thyroid carcinoma: preliminary results[J].World J Surg,2019, 43:1029-1037.
[16]Alam F, Naito K, Horiguchi J, et al. Accuracy of sonographic elastography in the differential diagnosis of enlarged cervical lymph nodes: comparison with conventional B-mode sonography[J]. AJR Am J Roentgenol,2008,191:604-610.
[17]Meng W, Xing P, Chen Q, et al. Initial experience of acoustic radiation force impulse ultrasound imaging of cervical lymph nodes[J]. Eur J Radiol,2013,82:1788-1792.
[18]Li T, Li H, Xue J, et al. Shear wave elastography combined with gray-scale ultrasound for predicting central lymph node metastasis of papillary thyroid carcinoma[J]. Surg Oncol, 2021,36:1-6..
[19]Khadra H, Mohamed H, Al-Qurayshi Z, et al. Superior detection of metastatic cystic lymphadenopathy in patients with papillary thyroid cancer by utilization of thyroglobulin washout[J]. Head Neck,2019,41:225-229.
[20]Chung SR, Baek JH, Choi YJ, et al. Diagnostic algorithm for mtastatic lymph nodes of differentiated thyroid carcinoma[J]. cancers (Basel),2021,13:1338.doi: 10.3390/cancers13061338.
[21]Zhang XT,Howell JM,Huang YJ. Cervical lymph node fine-needle aspiration and needle-wash thyroglobulin reflex test for papillary thyroid carcinoma[J].Endocr Pathol,2018,29:346-350.
[22]Lee JH, Baek JH, Kim JH, et al. Deep learning-based computer-aided diagnosis system for localization and diagnosis of metastatic lymph nodes on ultrasound: a pilot study[J]. Thyroid,2018,28:1332-1338.
[23]Wu Y, Rao K, Liu J, et al. Machine learning algorithms for the prediction of central lymph node metastasis in patients with papillary thyroid cancer[J].Front Endocrinol (Lausanne), 2020,11:577537.doi: 10.3389/fendo.2020.577537.
[24]于婧,王凤琴,姚文娟,等.甲状腺乳头状癌BRAF V600E 基因突变对 VEGF 和 MMP-9 表达的影响[J].基础医学与临床2019,39:1578-1582.
[25]Chen P,Pan LQ, Huang WS, et al. BRAF V600E and lymph node metastases in papillary thyroid cancer[J].Endocr Connect,2020, 9: 999-1008.

超声检查评估分化型甲状腺癌颈部转移淋巴结的研究进展

Progress in evaluation of cervical metastatic lymph nodes of differentiated thyroid cancer with ultrasonography

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 3

编辑推荐

Metrics

本文评价

[1]	李志锋陈美青靳松张刚赵芝孙同伟. NOB1在人胃癌组织中高表达及临床意义[J]. 基础医学与临床, 2015, 35(11): 1546-1548.
[2]	李涛傅丽兰刘子文. 临床N0期甲状腺乳头状癌颈部淋巴结隐匿性转移规律的分析[J]. 基础医学与临床, 2014, 34(8): 1071-1075.
[3]	郭旭峰陈勇兵徐忠恒徐中华杨文涛钱永跃. VEGF-C 对肺癌细胞淋巴结转移及凋亡的影响[J]. 基础医学与临床, 2010, 30(2): 203-204.